SEC Form 13F
| Report period | 2024-12-31 |
|---|---|
| Publicly available | 2025-02-12 |
| Reported value | $61,250,709,000 |
| Positions | 26 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| ENDEAVOR GROUP HLDGS INC | EDR | CL A COM | $28,739,740,000 | 918,496 |
| ISHARES TR | HYG | IBOXX HI YD ETF | $10,189,108,000 | 129,550 |
| INVESCO EXCH TRADED FD TR II | BKLN | SR LN ETF | $10,166,465,000 | 482,509 |
| CORE SCIENTIFIC INC NEW | CORZ | COM | $5,648,283,000 | 402,013 |
| ARBUTUS BIOPHARMA CORP | ABUS | COM | $2,231,732,000 | 682,487 |
| EVOLV TECHNOLOGIES HLDNGS IN | EVLV | COM CL A | $1,394,350,000 | 353,000 |
| NAVITAS SEMICONDUCTOR CORP | NVTS | COM | $772,959,000 | 216,515 |
| ARCHER AVIATION INC | Unresolved | *W EXP 09/16/202 | $657,509,000 | 204,189 |
| ROIVANT SCIENCES LTD | ROIV | SHS | $551,763,000 | 46,641 |
| ALPHA TAU MEDICAL LTD | Unresolved | *W EXP 99/99/999 | $201,701,000 | 960,479 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.